The Controlling Nutritional Status (CONUT) Score as a Predictor of Local Recurrence in Patients Underwent Partial Nephrectomy Alongside the R.E.N.A.L. Nephrometry Score
Urology Journal,
Vol. 21 No. 05 (2024),
12 October 2024
,
Page 313-319
https://doi.org/10.22037/uj.v21i.8045
Abstract
Purpose: This study aims to assess the utility of the CONUT (Controlling Nutritional Status) Score and R.E.N.A.L.
(Renal Nephrometry Score) Score in predicting tumor recurrence in patients with kidney cancer. Additionally, we
investigated which parameters contributed to these scores.
Materials and Methods: In total, 115 patients who underwent partial nephrectomy between January 2015 and
August 2023 at a single tertiary center were enrolled. After the exclusion criteria, data from 88 patients were
analyzed. Age, gender, body mass index (BMI), comorbidities (hypertension, diabetes), smoking status, tumor
characteristics, CONUT Scores, and R.E.N.A.L. scores were retrospectively recorded. Statistical analyses were
performed, and significant p was p < 0.05.
Results: The presence of diabetes and hypertension showed a statistically significant association with tumor recurrence (p = 0.033 and p = 0.003, respectively). A high BMI significantly increased the risk of recurrence (p < 0.05).
There was a strong positive relationship between the high tumor stage and positive surgical margins with recurrence (p < 0.001). Patients with high R.E.N.A.L. Scores and high CONUT Scores had a higher risk of recurrence
(42.1% and 8.7%, respectively), and this difference was statistically significant (p < 0.001).
Conclusion: CONUT and R.E.N.A.L. scores may be used to predict tumor recurrence after partial nephrectomy.
Additionally, diabetes, hypertension, high BMI, and positive surgical margin rate might affect surgical success
rate for recurrences. Clinicians should consider all these parameters and coring systems to gather more successful
results after partial nephrectomy.
- CONUT Score
- Predictive
- Partial Nephrectomy
- R.E.N.A.L. Nephrometry Score
How to Cite
References
Kidney and Renal Pelvis Cancer — Cancer Stat Facts. Available from: https://seer.cancer.gov/statfacts/html/kidrp.html
Choyke PL, Glenn GM, Walther MM, Zbar B, Linehan WM. Hereditary renal cancers. Radiology. 2003;226:33-46.
Bahadoram S, Davoodi M, Hassanzadeh S, Bahadoram M, Barahman M, Mafakher L. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. G Ital Nefrol. 2022;20;39
Kunath F, Schmidt S, Krabbe LM, et.al. Partial nephrectomy versus radical nephrectomy for clinical localised renal masses. Cochrane Database Syst Rev. 2017;9;5
Kolla SB, Spiess PE, Sexton WJ. Interobserver reliability of the RENAL nephrometry scoring system. Urology. 2011;78:592-4
Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009;182:844-53
Veccia A, Antonelli A, Uzzo RG, et.al. Predictive Value of Nephrometry Scores in Nephron-sparing Surgery: A Systematic Review and Meta-analysis. Eur Urol Focus. 2020;15;6:490-504.
Campbell RA, Scovell J, Rathi N, et.al. Partial Versus Radical Nephrectomy: Complexity of Decision-Making and Utility of AUA Guidelines. Clin Genitourin Cancer. 2022;20:501-509.
Klatte T, Ficarra V, Gratzke C, et al. A Literature Review of Renal Surgical Anatomy and Surgical Strategies for Partial Nephrectomy. Eur Urol. 2015;68:980-92
Ficarra V, Novara G, Secco S, Macchi V, Porzionato A, De Caro R, Artibani W. Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol. 2009;56:786-93
Kriegmair MC, Mandel P, Moses A, Bolenz C, Michel MS, Pfalzgraf D. Zonal NephRo Score: external validation for predicting complications after open partial nephrectomy. World J Urol. 2016;34:545-51
Ignacio de Ulíbarri J, González-Madroño A, de Villar NG, et al. CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutricion Hospitalaria. 2005;20:38-45.
Takagi K, Buettner S, Ijzermans JNM. Prognostic significance of the controlling nutritional status (CONUT) score in patients with colorectal cancer: A systematic review and meta-analysis. Int J Surg. 2020;78:91-96.
Aoyama T, Komori K, Nakazano M, et al. The Clinical Influence of the CONUT Score on Survival of Patients With Gastric Cancer Receiving Curative Treatment. In Vivo. 2022;36:942-948
Dang C, Wang M, Zhu F, Qin T, Qin R. Controlling nutritional status (CONUT) score-based nomogram to predict overall survival of patients with pancreatic cancer undergoing radical surgery. Asian J Surg. 2022;45:1237-1245.
Senjo H, Onozawa M, Hidaka D, et al. A novel nutritional index "simplified CONUT" and the disease risk index independently stratify prognosis of elderly patients with acute myeloid leukemia. Sci Rep. 2020;10;10:19400.
Takagi K, Buettner S, Ijzermans JNM. Prognostic significance of the controlling nutritional status (CONUT) score in patients with colorectal cancer: A systematic review and meta-analysis. Int J Surg. 2020;78:91-96.
Miano N, Di Marco M, Alaimo S, et al. Controlling Nutritional Status (CONUT) Score as a Potential Prognostic Indicator of In-Hospital Mortality, Sepsis and Length of Stay in an Internal Medicine Department. Nutrients. 2023; 15(7):1554.
Ye SL, Xiang GY, Liu Z, et al The controlling nutritional status score predicts postoperative mortality in patients with ruptured abdominal aortic aneurysm: a retrospective study. Front Cardiovasc Med. 2023;27;10:1129255
Son HW, Yu G, Lee SJ, Oh J. Impact of Controlling Nutritional Status score on short-term outcomes after carotid endarterectomy: a retrospective cohort study. J Yeungnam Med Sci. 2023;40:259-267.
Carmen NE. Malnutrion In Patient Cancer. Influence: International Journal of Science Review;5(1):29–38
Yorulmaz, E. M., Özcan, S., Görgel, S. N., Köse, O., & Akın, Y. (2023). The role of preoperative conut score in prognosis in patients with radical cystectomy. Mathews Journal of Urology and Nephrology, 5(1).
Zheng Y, Bao L, Wang W, Wang Q, Pan Y, Gao X. Prognostic impact of the Controlling Nutritional Status score following curative nephrectomy for patients with renal cell carcinoma. Medicine (Baltimore). 2018;97:e13409.
Xu H, Tan P, Jin X, et al. Validation of the preoperative controlling nutritional status score as an independent predictor in a large Chinese cohort of patients with upper tract urothelial carcinoma. Cancer Med. 2018;7:6112-6123.
Kang HW, Seo SP, Kim WT, et al; KORCC (KOrean Renal Cell Carcinoma) group. Prognostic Impact of Nutritional Status Assessed by the Controlling Nutritional Status (CONUT) Score in Patients with Surgically Treated Renal Cell Carcinoma. Nutr Cancer. 2018;70:886-894.
Ishihara H, Kondo T, Yoshida K, et al. Preoperative controlling nutritional status (CONUT) score as a novel predictive biomarker of survival in patients with localized urothelial carcinoma of the upper urinary tract treated with radical nephroureterectomy. Urol Oncol. 2017;35:539.e9-539.e16.
Elghiaty A, Kim J, Jang WS, et al. Preoperative controlling nutritional status (CONUT) score as a novel immune-nutritional predictor of survival in non-metastatic clear cell renal cell carcinoma of ≤ 7 cm on preoperative imaging. J Cancer Res Clin Oncol. 2019;145(4):957-965.
Song H, Xu B, Luo C, et al. The prognostic value of preoperative controlling nutritional status score in non-metastatic renal cell carcinoma treated with surgery: a retrospective single-institution study. Cancer Manag Res. 2019;9;11:7567-7575.
White MA, Haber GP, Autorino R, et al. Outcomes of robotic partial nephrectomy for renal masses with nephrometry score of ≥7. Urology. 2011;77(4):809-13.
Castle SM, Gorbatiy V, Leveillee RJ. Robotic partial nephrectomy outcomes at a single institution and experience with R.E.N.A.L. nephrometry score. J Robot Surg. 2011;5(3):209-14.
Yang H, Yin K, Wang Y, et al. Pre-existing type 2 diabetes is an adverse prognostic factor in patients with renal cell carcinoma. J Diabetes. 2019;11(12):993-1001.
Huang J, Leung DK, Chan EO, et al. A Global Trend Analysis of Kidney Cancer Incidence and Mortality and Their Associations with Smoking, Alcohol Consumption, and Metabolic Syndrome. Eur Urol Focus. 2022;8(1):200-209.
Tahbaz R, Schmid M, Merseburger AS. Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutrition. Curr Opin Urol. 2018;28(1):62-79.
Bukavina L, Bensalah K, Bray F, et al. Epidemiology of Renal Cell Carcinoma: 2022 Update. Eur Urol. 2022;82(5):529-542.
Capitanio U, Bensalah K, Bex A, et al. Epidemiology of Renal Cell Carcinoma. Eur Urol. 2019;75(1):74-84.
Gansler T, Fedewa SA, Flanders WD, Pollack LA, Siegel DA, Jemal A. Prevalence of Cigarette Smoking among Patients with Different Histologic Types of Kidney Cancer. Cancer Epidemiol Biomarkers Prev. 2020;29(7):1406-1412.
Graff RE, Wilson KM, Sanchez A, et al. Obesity in Relation to Renal Cell Carcinoma Incidence and Survival in Three Prospective Studies. Eur Urol. 2022;82(3):247-251.
Choi Y, Park B, Jeong BC, Seo SI, Jeon SS, Choi HY, Adami HO, Lee JE, Lee HM. Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis. Int J Cancer. 2013;1;132(3):625-34.
Rogde AJ, Gudbrandsdottir G, Hjelle KM, Sand KE, Bostad L, Beisland C. Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma. Scand J Urol Nephrol. 2012;46(5):348-57.
Ray S, Cheaib JG, Biles MJ, et al. Local and Regional Recurrences of Clinically Localized Renal Cell Carcinoma after Nephrectomy: A 15 Year Institutional Experience with Prognostic Features and Oncologic Outcomes. Urology. 2021;154:201-207.
Abu-Ghanem Y, Ramon J, Berger R, et al. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival. World J Surg Oncol. 2017;2;15:193.
- Abstract Viewed: 520 times
- 8045/pdf Downloaded: 298 times